• Consensus Rating: Hold
  • Consensus Price Target: $20.33
  • Forecasted Upside: 16.32%
  • Number of Analysts: 9
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$17.48
▼ -0.2 (-1.13%)

This chart shows the closing price for CNK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cinemark Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNK

Analyst Price Target is $20.33
▲ +16.32% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Cinemark in the last 3 months. The average price target is $20.33, with a high forecast of $24.00 and a low forecast of $12.00. The average price target represents a 16.32% upside from the last price of $17.48.

This chart shows the closing price for CNK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 9 contributing investment analysts is to hold stock in Cinemark. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
11/29/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
2/27/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/28/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
8/26/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
11/24/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
2/22/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
4/22/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/22/2024

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2024Barrington ResearchReiterated RatingOutperform ➝ Outperform$24.00 ➝ $24.00Low
5/3/2024BenchmarkReiterated RatingBuy ➝ Buy$23.00Low
5/3/2024B. RileyBoost TargetNeutral ➝ Neutral$14.00 ➝ $16.00Low
4/25/2024WedbushReiterated RatingOutperform ➝ Outperform$23.00 ➝ $23.00Low
4/22/2024Barrington ResearchReiterated RatingOutperform ➝ Outperform$24.00 ➝ $24.00Low
4/18/2024WedbushBoost TargetOutperform ➝ Outperform$20.00 ➝ $23.00Low
4/10/2024Roth MkmBoost TargetNeutral ➝ Neutral$17.00 ➝ $19.00Low
4/10/2024BenchmarkReiterated RatingBuy ➝ Buy$22.00Low
4/8/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$17.00 ➝ $19.00Low
4/5/2024Wells Fargo & CompanyUpgradeUnderweight ➝ Overweight$13.00 ➝ $23.00Low
4/3/2024BenchmarkReiterated RatingBuy ➝ Buy$22.00Low
2/13/2024WedbushReiterated RatingOutperform ➝ Outperform$20.00Low
2/6/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$18.00 ➝ $16.00Low
1/11/2024The Goldman Sachs GroupLower TargetSell ➝ Sell$16.00 ➝ $12.00Low
1/2/2024B. RileyDowngradeBuy ➝ Neutral$23.00 ➝ $15.00Low
12/20/2023Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$16.00 ➝ $13.00Low
12/5/2023Roth MkmLower TargetNeutral$20.00 ➝ $16.00Low
10/30/2023WedbushReiterated RatingOutperform$20.00 ➝ $22.00Low
10/24/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$18.00 ➝ $16.00Low
10/6/2023BenchmarkBoost TargetBuy ➝ Buy$21.00 ➝ $22.00Low
9/19/2023BenchmarkReiterated RatingBuy ➝ Buy$21.00Low
8/7/2023Barrington ResearchReiterated RatingOutperform ➝ Outperform$20.00 ➝ $22.00Low
8/7/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$22.00 ➝ $24.00Low
8/7/2023WedbushReiterated RatingOutperform ➝ Outperform$20.00Low
8/7/2023B. RileyBoost Target$23.00 ➝ $24.00Low
8/1/2023WedbushReiterated RatingOutperform ➝ Outperform$20.00Low
7/19/2023JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$21.00 ➝ $18.00N/A
7/18/2023Morgan StanleyReiterated RatingOverweight ➝ Overweight$22.00Low
7/12/2023B. RileyUpgradeNeutral ➝ Buy$23.00 ➝ $20.00Low
6/14/2023B. RileyDowngradeBuy ➝ Neutral$21.00 ➝ $20.00Low
5/9/2023Barrington ResearchBoost Target$19.00 ➝ $20.00Low
5/8/2023Morgan StanleyBoost Target$21.00 ➝ $22.00Low
5/8/2023B. RileyBoost Target$20.00 ➝ $21.00Low
4/21/2023The Goldman Sachs GroupBoost TargetSell$11.00 ➝ $12.50Low
4/17/2023Morgan StanleyBoost TargetOverweight$16.00 ➝ $21.00Low
4/10/2023BenchmarkReiterated RatingBuy$17.00Low
4/10/2023B. RileyBoost TargetBuy$15.00 ➝ $20.00Low
4/6/2023Credit Suisse GroupBoost TargetNeutral$12.00 ➝ $14.00N/A
3/28/2023BenchmarkReiterated RatingBuy$17.00Low
2/27/2023BenchmarkReiterated RatingBuy$17.00Low
2/27/2023JPMorgan Chase & Co.Boost TargetOverweight$15.00 ➝ $17.00Low
2/27/2023B. RileyBoost TargetBuy$13.00 ➝ $15.00Low
2/22/2023Credit Suisse GroupUpgradeUnderperform ➝ Neutral$9.00 ➝ $12.00Low
2/13/2023Roth CapitalReiterated RatingNeutralLow
1/17/2023Morgan StanleyReiterated RatingOverweight$16.00Low
1/12/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$15.00Low
1/3/2023B. RileyLower TargetBuy$16.00 ➝ $13.00Low
12/21/2022BenchmarkLower TargetBuy$22.00 ➝ $17.00Low
11/7/2022Wells Fargo & CompanyLower TargetEqual Weight$18.00 ➝ $15.00Low
11/7/2022B. RileyLower Target$17.00 ➝ $16.00Low
10/27/2022Morgan StanleyLower TargetOverweight$22.00 ➝ $16.00Low
10/12/2022B. RileyLower TargetBuy$23.00 ➝ $17.00Low
10/12/2022Credit Suisse GroupDowngradeOutperform ➝ Underperform$25.00 ➝ $9.00Low
10/11/2022The Goldman Sachs GroupLower TargetSell$12.50 ➝ $11.00Low
10/10/2022JPMorgan Chase & Co.Lower TargetNeutral$19.00 ➝ $15.00Low
10/5/2022BenchmarkLower Target$27.00 ➝ $22.00Low
8/8/2022Wells Fargo & CompanyLower TargetEqual Weight$22.00 ➝ $18.00Low
8/2/2022WedbushReiterated RatingOutperform$22.00Low
7/19/2022BenchmarkSet Target$27.00Low
7/19/2022Morgan StanleyUpgradeEqual Weight ➝ Overweight$22.00Low
6/21/2022B. RileyLower TargetBuy$29.00 ➝ $23.00Low
4/13/2022B. RileyLower TargetBuy$31.00 ➝ $29.00Medium
3/7/2022The Goldman Sachs GroupLower TargetSell$15.40 ➝ $13.60High
3/7/2022Barrington ResearchLower Target$26.00 ➝ $22.00High
2/28/2022Wells Fargo & CompanyLower TargetEqual Weight$24.00 ➝ $22.00Low
2/22/2022WedbushReiterated RatingOutperform$32.00Medium
12/15/2021Morgan StanleyLower TargetEqual Weight$24.00 ➝ $22.00High
11/9/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform$16.00 ➝ $25.00Medium
10/22/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$22.00High
10/15/2021Morgan StanleyBoost TargetEqual Weight$20.00 ➝ $24.00Medium
10/11/2021B. RileyBoost TargetOutperform ➝ Buy$28.00 ➝ $31.00High
7/29/2021Morgan StanleyLower TargetEqual Weight$25.00 ➝ $20.00Medium
6/2/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$21.00 ➝ $19.00High
4/19/2021Morgan StanleyBoost TargetEqual Weight$17.00 ➝ $25.00High
3/3/2021Barrington ResearchBoost TargetOutperform$22.00 ➝ $26.00High
3/3/2021BenchmarkBoost TargetBuy$21.00 ➝ $30.00Low
3/1/2021Loop CapitalDowngradeBuy ➝ Hold$22.00Low
2/24/2021WedbushReiterated RatingBuyHigh
2/23/2021WedbushBoost TargetOutperform$15.00 ➝ $28.00Low
2/1/2021MKM PartnersDowngradeBuy ➝ Neutral$15.00 ➝ $22.00Low
1/25/2021The Goldman Sachs GroupBoost TargetNeutral$11.00 ➝ $16.00High
1/15/2021Moffett NathansonBoost Target$12.00 ➝ $14.00Low
1/15/2021B. RileyUpgradeNeutral ➝ Buy$14.00 ➝ $28.00High
11/19/2020Loop CapitalDowngradeBuy ➝ HoldMedium
11/17/2020B. RileyBoost TargetPositive ➝ Neutral$11.00 ➝ $14.00High
11/9/2020Barrington ResearchUpgradeMarket Perform ➝ OutperformHigh
11/4/2020Morgan StanleyLower TargetEqual Weight$15.00 ➝ $12.00Low
10/26/2020Barrington ResearchDowngradeOutperform ➝ Market PerformHigh
10/12/2020B. RileyLower TargetNeutral$14.00 ➝ $11.00Low
10/9/2020MKM PartnersLower TargetBuy$18.00 ➝ $15.00High
10/5/2020Loop CapitalLower TargetBuy$18.00 ➝ $16.00High
8/20/2020BenchmarkUpgradeHold ➝ Buy$18.00High
8/5/2020JPMorgan Chase & Co.Lower Target$23.00 ➝ $19.00Medium
8/4/2020Barrington ResearchReiterated RatingBuy$20.00High
8/3/2020Morgan StanleyLower TargetEqual Weight$18.00 ➝ $15.00High
7/29/2020WedbushLower TargetOutperform$20.00 ➝ $15.00High
7/15/2020The Goldman Sachs GroupInitiated CoverageNeutral$12.00High
7/13/2020MKM PartnersLower TargetBuy$21.00 ➝ $18.00High
6/29/2020Credit Suisse GroupDowngradeOutperform ➝ Neutral$20.00 ➝ $13.00High
6/26/2020B. RileyReiterated RatingHold$16.00High
6/19/2020Imperial CapitalLower TargetOutperform$24.00 ➝ $23.00High
6/4/2020B. RileyBoost Target$13.00 ➝ $16.00High
6/4/2020MKM PartnersBoost TargetBuy$19.00 ➝ $21.00Medium
6/4/2020Credit Suisse GroupLower TargetOutperform$22.00 ➝ $20.00High
6/3/2020Barrington ResearchReiterated RatingBuy$20.00Low
6/1/2020Morgan StanleyLower TargetEqual Weight$20.00 ➝ $18.00Medium
5/29/2020WedbushReiterated RatingBuy$20.00Medium
5/26/2020Imperial CapitalLower TargetOutperform$26.00 ➝ $24.00High
5/18/2020B. RileyDowngradeBuy ➝ Neutral$16.00 ➝ $13.00High
4/23/2020MacquarieUpgradeNeutral ➝ Outperform$20.00Medium
4/16/2020Barrington ResearchReiterated RatingBuy$20.00Low
4/14/2020MKM PartnersLower TargetBuy$32.00 ➝ $19.00High
4/13/2020B. RileyUpgradeBuy$14.00 ➝ $16.00Low
4/8/2020Loop CapitalLower Target$35.00 ➝ $22.00Low
4/6/2020B. RileyUpgradeNeutral ➝ BuyHigh
4/1/2020B. RileyLower TargetNeutral ➝ Neutral$17.00 ➝ $14.00High
3/25/2020Barrington ResearchLower TargetOutperform ➝ Hold$35.00 ➝ $20.00Low
3/25/2020Morgan StanleyLower TargetEqual Weight$33.00 ➝ $20.00Low
3/25/2020Imperial CapitalLower TargetOutperform$45.00 ➝ $26.00High
3/24/2020Credit Suisse GroupLower TargetOutperform$22.00 ➝ $18.00High
3/20/2020WedbushReiterated RatingBuy$39.00 ➝ $20.00High
3/18/2020B. RileyLower TargetNeutral$32.00 ➝ $17.00High
3/17/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$32.00 ➝ $20.00High
3/10/2020JPMorgan Chase & Co.Lower TargetOverweight$39.00 ➝ $32.00High
3/6/2020MKM PartnersLower TargetBuy$36.00 ➝ $32.00High
2/24/2020B. RileyLower TargetNeutral$36.00 ➝ $32.00Medium
2/24/2020Morgan StanleyLower TargetEqual Weight$34.00 ➝ $33.00Medium
2/24/2020JPMorgan Chase & Co.Reiterated RatingBuy$40.00 ➝ $39.00High
2/21/2020Barrington ResearchReiterated RatingBuy$49.00High
2/12/2020MKM PartnersLower TargetBuy$42.00 ➝ $36.00Low
2/3/2020WedbushLower TargetOutperform$45.00 ➝ $40.00Medium
1/10/2020Imperial CapitalLower TargetOutperform$48.00 ➝ $45.00Medium
1/3/2020Loop CapitalLower TargetBuy$42.00Medium
11/22/2019B. RileyDowngradeBuy ➝ Neutral$46.50 ➝ $37.00Medium
11/5/2019WedbushReiterated RatingBuy$45.00Low
11/5/2019Barrington ResearchReiterated RatingBuy$49.00Low
10/29/2019WedbushReiterated RatingBuy$49.00Low
10/21/2019WedbushSet TargetBuy$49.00Low
10/15/2019MacquarieSet TargetHold$42.00Low
10/15/2019The Goldman Sachs GroupSet TargetBuy$43.00Low
9/10/2019MKM PartnersLower TargetBuy$45.00 ➝ $43.00Medium
8/2/2019WedbushReiterated RatingBuy$49.00Medium
7/23/2019Morgan StanleyLower TargetEqual Weight$41.00 ➝ $37.00Low
7/19/2019Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$43.00 ➝ $43.00Medium
7/15/2019MKM PartnersLower TargetBuy$43.00Low
7/3/2019Loop CapitalUpgradeHold ➝ Buy$44.00Medium
(Data available from 5/22/2019 forward)

News Sentiment Rating

0.87 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
10/25/2023
  • 10 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/24/2023
  • 2 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
12/24/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
1/23/2024
  • 17 very positive mentions
  • 18 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
2/22/2024
  • 14 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/23/2024
  • 10 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/22/2024
  • 18 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2024

Current Sentiment

  • 18 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Cinemark logo
Cinemark Holdings, Inc., together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc. was founded in 1984 and is headquartered in Plano, Texas.
Read More

Today's Range

Now: $17.48
Low: $17.35
High: $17.89

50 Day Range

MA: $18.03
Low: $17.02
High: $19.78

52 Week Range

Now: $17.48
Low: $13.19
High: $20.40

Volume

2,552,994 shs

Average Volume

2,881,044 shs

Market Capitalization

$2.14 billion

P/E Ratio

12.06

Dividend Yield

N/A

Beta

2.25

Frequently Asked Questions

What sell-side analysts currently cover shares of Cinemark?

The following Wall Street research analysts have issued stock ratings on Cinemark in the last twelve months: B. Riley, Barrington Research, Benchmark Co., JPMorgan Chase & Co., Morgan Stanley, Roth Mkm, StockNews.com, The Goldman Sachs Group, Inc., Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for CNK.

What is the current price target for Cinemark?

9 Wall Street analysts have set twelve-month price targets for Cinemark in the last year. Their average twelve-month price target is $20.33, suggesting a possible upside of 16.3%. Morgan Stanley has the highest price target set, predicting CNK will reach $24.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $12.00 for Cinemark in the next year.
View the latest price targets for CNK.

What is the current consensus analyst rating for Cinemark?

Cinemark currently has 1 sell rating, 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CNK, but not buy more shares or sell existing shares.
View the latest ratings for CNK.

What other companies compete with Cinemark?

How do I contact Cinemark's investor relations team?

Cinemark's physical mailing address is 3900 DALLAS PARKWAY, PLANO TX, 75093. The company's listed phone number is (972) 665-1000 and its investor relations email address is [email protected]. The official website for Cinemark is www.cinemark.com. Learn More about contacing Cinemark investor relations.